| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 04/13/2006 | US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 04/12/2006 | EP1644381A1 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug |
| 04/12/2006 | EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 04/12/2006 | CN1759119A Method for the decarboxylation of dicarboxylic acids |
| 04/12/2006 | CN1757645A Material contg. thiophene spirane structure, its synthesis and application |
| 04/12/2006 | CN1250554C Preparing method for nanometer powder of synthetic metal ET salt |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250528C Cyclic nitrones and pharmaceutical compositions containing them |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7025900 Perylenetetracarboxylic acid dibenzimidazole sulfoderivatives containing oxo-groups in the perylene core which form part of a para-quinoid system of bonds, lyotropic liquid crystal systems and anisotropic films containing the same, and methods for making the same |
| 04/06/2006 | WO2006036266A1 Thienopyrimidines useful as aurora kinase inhibitors |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2005107375A3 Process for the preparation of olanzapine form-i |
| 04/06/2006 | US20060074125 Novel dithiolopyrrolones with therapeutic activity |
| 04/06/2006 | US20060074102 Kinase inhibitors as therapeutic agents |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/06/2006 | CA2573999A1 Thienopyrimidines useful as aurora kinase inhibitors |
| 04/05/2006 | EP1642896A1 Pentafluorosulfanyl-substituted thienothiophene monomers and conducting polymers |
| 04/05/2006 | EP1642895A2 Novel substituted naphthopyrans |
| 04/05/2006 | EP1641804A1 Thienopyridone derivatives as kinase inhibitors |
| 04/05/2006 | EP1641803A1 Thienopyrimidine derivatives as potassium channel inhibitors |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249049C Cyclic disulfide, producing process thereof and optical products containing the same |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/04/2006 | US7022811 3,4-Alkylenedioxythiophene compounds and polymers thereof |
| 04/04/2006 | US7022736 Enzyme inhibitors |
| 04/04/2006 | US7022731 Cardiovascular disorders; thrombosis; anticoagulants |
| 04/04/2006 | US7022698 Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof |
| 04/04/2006 | CA2166315C Process for the preparation of thalidomide |
| 03/30/2006 | WO2006034511A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 03/30/2006 | WO2006034451A2 Crystalline clopidogrel hydrobromide and processes for preparation thereof |
| 03/30/2006 | WO2006034090A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 03/30/2006 | WO2006034015A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors |
| 03/30/2006 | WO2006033406A1 Method for producing cyclic sulfide compound and intermediate thereof |
| 03/30/2006 | WO2006033405A1 Cyclic sulfide compound and optical article using same |
| 03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 03/30/2006 | WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 03/30/2006 | WO2005097107A3 Diphenyl - indol-2-on compounds and their use in the treatment of cancer |
| 03/30/2006 | WO2005081960A3 Inhibitors of protein tyrosine phosphatase 1b |
| 03/30/2006 | WO2005037825A3 Protein kinase inhibitors |
| 03/30/2006 | US20060069149 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases |
| 03/30/2006 | US20060069138 Thiazole-based nitric oxide donors having alkyl substuent(s) and uses thereof |
| 03/30/2006 | US20060069116 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/30/2006 | US20060069102 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease |
| 03/30/2006 | US20060069041 Bioavailability; acid, amine, or polyhydroxy-functionalized; e.g. mono-[1-(4,8-dioxo-4,8-dihydrobenzo[1,2-b;5,4-b']dithiophen-2-yl)-methyl]succinate; antitumor agents; non-small cell lung cancer, breast cancer, nasopharynx carcinoma and prostate cancer |
| 03/30/2006 | CA2581175A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 03/30/2006 | CA2581150A1 (spirocyclylamido) aminothiophene compounds as c-kit proto- oncogene inhibitors |
| 03/30/2006 | CA2580777A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators |
| 03/30/2006 | CA2580725A1 Novel heterocyclic nf-kb inhibitors |
| 03/29/2006 | EP1638980A1 Process for preparing 3-aminothienopyridone derivatives |
| 03/29/2006 | EP1638979A1 Thienopyridone derivatives as kinase inhibitors |
| 03/29/2006 | EP1638957A1 N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 03/29/2006 | CN1753899A Spirotetrathiocarbamates and spirooxothiocarbamates |
| 03/29/2006 | CN1247594C Bicyclic heteroaromatic compounds |
| 03/29/2006 | CN1247593C Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 03/29/2006 | CN1247581C Processes for the preparation of carbapenem-type antibacterial agents |
| 03/28/2006 | US7019453 For use as optical modulators, optical switches, and optical directional couplers |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | CA2343459C Pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/28/2006 | CA2290392C Salts of optically active sulfoxide derivative |
| 03/23/2006 | WO2006031893A2 Fused thiophenes, methods for making fused thiophenes, and uses thereof |
| 03/23/2006 | WO2006030300A2 Processes for the preparation of olanzapine |
| 03/23/2006 | WO2006030031A1 Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols |
| 03/23/2006 | WO2006004884A3 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 03/23/2006 | WO2005023819A9 Thienopyrroles as antiviral agents |
| 03/23/2006 | US20060063037 acts as a hole injection material, a hole transport material, a light emitting host, or a light emitting dopant in the organic light emitting device depending on the type of substituent |
| 03/23/2006 | DE102005031554A1 Difluoro-substituted heterocyclic compounds (e.g. chromanes or chromenes) are prepared by fluorination of novel intermediates and are useful in liquid crystal media e.g. in vertical alignment (VA) displays are new |
| 03/23/2006 | CA2580656A1 Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | CA2580627A1 Nitrate esters and their use for mitigating cellular damage |
| 03/23/2006 | CA2580328A1 Iodine-phenyl-substituted cyclic ketoenols |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637529A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof |
| 03/22/2006 | EP1636238A1 Heteroryl-fused pyrimidinyl compounds as anticancer agents |
| 03/22/2006 | EP1636218A1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/22/2006 | EP1636216A1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/22/2006 | EP1635840A1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors |
| 03/22/2006 | EP1635839A2 Benzo[4,5]thieno[2,3-d]pyrimidin-4-ones and their use in therapy |
| 03/22/2006 | EP1497296B1 [1,4]DIAZOCINO[7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 03/22/2006 | EP1436296B1 Process for the direct preparation of pyrrolo[3,4-c]pyrroles |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | CN1751050A Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
| 03/22/2006 | CN1749254A Double spiro material containing heteroaton and its synthetic method and use |
| 03/22/2006 | CN1246324C Thieno [2,3-d] pyrimidines with combined LH and FSH agonistic activity |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | US7015213 Use of diazepines for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/20/2006 | WO2006102191A1 Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| 03/20/2006 | CA2600175A1 Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors |
| 03/16/2006 | WO2006028284A1 Morpholine compound |
| 03/16/2006 | WO2006027800A1 A novel process for preparation of a pharmaceutically pure polymorphic form 1 of olanzapine |
| 03/16/2006 | US20060058360 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride |